15.07.2015

New production area of the Asian leading biopharmaceutical company has been successfully authorized in Russia with the help of the ARS CRO regulatory team. The site is indented for producing antiviral generics of Efavirenz and Darunavir and now is included in the drugs’ registration dossiers.